Dexmethylphenidate Hydrochloride 00093-5562
Product NDC
00093-5562- Manufacturer
- Teva Pharmaceuticals Usa, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- November 21, 2013
- Listing Expires
- December 31, 2026
- Application
- ANDA202731
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dexmethylphenidate Hydrochloride | 40 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-5562-01)